Cardiology

Heart Failure: Targeting the right patients for CRT-D

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial. The CRT-MADIT-CRT trial ...

page 6 from 7